Menopause Position Statements

“If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your…”. Meno Martha

Umbrella
What may the Menopause Position Statements Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Clinical Guides
  • Consensus Statements
  • Final Recommendation Statements
  • Global Consensus Statements
  • Guidelines
  • Other Reports
  • Position Papers
  • Position Statements
  • Recommendations
  • Reports
  • Statements
  • White Paper

Date

Menopause Position StatementsWhat can it be important to be clear about with menopause position statements?

It can be important to be clear about the date of all information including the date of menopause position statements because this information may have been updated or retired.

Health Care Provider

What if I would like to find out what menopause position statement information is applicable to me?

If you would like to find out what menopause position statements are applicable to you, it may be in your best interest to choose to talk to your health care provider about this.

Health Topics A-Z

Where may I find Health Topics related to Menopause Position Statements?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Menopause Position Statements?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

    • BMS   = British Menopause Society
    • EMAS = European Menopause and Andropause Society
    • IGCS  = International Gynecologic Cancer Society
    • IMS    = International Menopause Society
  1. 2016 IMS Recommendations on Women’s Midlife Health and Menopause Hormone Therapy
  2. Abnormal Uterine Bleeding In Perimenopause
  3. Assessment and Management of Bone Health In Women With Oestrogen Receptor-Positive Breast Cancer Receiving Endocrine Therapy
  4. BMS & WHC’s 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  5. BMS Council Issues A Consensus Statement on Bioidentical Hormones
  6. BMS Vision: Vision for Menopause Care In the United Kingdom
  7. BMS, IMS, EMAS, RCOG and AMS Joint Statement on Menopausal Hormone Therapy (MHT) and Breast Cancer Risk
  8. Bioidentical HRT [British Menopause Society]
  9. Calcium In the Prevention of Postmenopausal Osteoporosis: EMAS Guide
  10. Cardiovascular Health After Menopause Transition, Pregnancy Disorders, and Other Gynaecologic Conditions: A Consensus Document From European Cardiologists, Gynaecologists, and Endocrinologists
  11. Cardiovascular Risk Assessment In Women – An Update
  12. Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
  13. Current Management of Pelvic Organ Prolapse In Aging Women: EMAS Clinical Guide
  14. EMAS Clinical Guides
  15. EMAS Position Statement: Menopause Symptom Management In Women With Dyslipidemias
  16. EMAS Position Statement: Predictors of Premature and Early Natural Menopause
  17. EMAS Position Statement: The Mediterranean Diet and Menopausal Health
  18. EMAS Position Statements
  19. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position Statement on Managing the Menopause After Gynecologic Cancer: Focus on Menopausal Symptoms and Osteoporosis
  20. Global Consensus Position Statement on the Use of Testosterone Therapy for Women Menopause Position Statements
  21. Global Consensus Recommendations on Menopause In the Workplace: A European Menopause and Andropause Society (EMAS) Position Statement
  22. Global Consensus Statement on Menopausal Hormone Therapy
  23. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
  24. Guidelines on Menopause: Clinical Practice Guidelines on Menopause: *An Executive Summary and Recommendations: Indian Menopause Society 2019–2020
  25. Guidelines on Osteoporosis: Clinical Practice Guidelines on Postmenopausal Osteoporosis: *An Executive Summary and Recommendations – Update 2019–2020
  26. Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions
  27. International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder In Women
  28. Management of Depressive Symptoms In Peri- and Postmenopausal Women: EMAS Position Statement
  29. Management of Osteoporosis In Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society
  30. Management of Urinary Incontinence In Postmenopausal Women: EMAS Clinical Guide
  31. Menopausal Hormone Therapy and Breast Cancer Risk: Individualization Is the Key To Safety
  32. Menopause and Diabetes: EMAS Clinical Guide
  33. Menopause: Diagnosis and Management – Information for the Public: Menopause [NICE Guidelines]
  34. NonHormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of the North American Menopause Society
  35. Pharmacological Management of Osteoporosis In Postmenopausal Women Guideline Resources
  36. Position Papers and Consensus Statements [International Menopause Society]
  37. Position Statement on Improving Bone Health and Osteoporosis Management In Australia
  38. Position Statements & Other Reports [North American Menopause Society]
  39. Position Statements [Australasian Menopause Society]
  40. Premature Ovarian Insufficiency [British Menopause Society]
  41. Prevention and Treatment of Osteoporosis In Women [British Menopause Society]
  42. Primary Prevention of Coronary Heart Disease In Women [British Menopause Society]
  43. Revised Global Consensus Statement on Menopausal Hormone Therapy
  44. The 2017 Hormone Therapy Position Statement of The North American Menopause Society
  45. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
  46. The British Menopause Society & Women’s Health Concern 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
  47. Topical Estrogens and Non-Hormonal Preparations for Postmenopausal Vulvovaginal Atrophy: An EMAS Clinical Guide
  48. Use of Compounded Hormone Therapy In the United States: Report of the North American Menopause Society Survey
  49. World Menopause Day 2016 – A White Paper – A White Paper – Cardiovascular Risk Assessment In Women – An Update [Multiply Languages]
  50. World Menopause Day 2017 – A White Paper – Abnormal Uterine Bleeding In Perimenopause [Multiply Languages]
  51. World Menopause Day 2018 – Sexual Well-Being After Menopause: An International Menopause Society White Paper [Multiply Languages]
  52. World Menopause Day 2019 – Global Consensus Position Statement on the Use of Testosterone Therapy for Women: A White Paper [Multiply Languages]
  53. World Menopause Day 2020 – Premature Ovarian Insufficiency: An International Menopause Society White Paper [Multiply Languages]
  54. World Menopause Day 2021 – Update on Bone Health: The IMS White Paper [Multiply Languages] Menopause Position Statements

Topic Last Updated: 08 December 2021 – Topic Last Reviewed: 08 December 2021
Print Friendly, PDF & Email
/by